Showing results (271-280 of 1,988) with videos related to

Sort By:
Pageof 199
Prostate Cancer and Prostatic Diseases|May 1, 2013
Prostate cancer susceptibility genes on 8p21-23 in a Dutch populationM P Zeegers, D Nekeman, H S Khan, et al.
Prostate Cancer and Prostatic Diseases|December 12, 2012
Temperature-dependent activation of differential apoptotic pathways during cryoablation in a human prostate cancer modelA T Robilotto, J M Baust, R G Van Buskirk, et al.
Prostate Cancer and Prostatic Diseases|January 23, 2013
High Nr-CAM expression is associated with favorable phenotype and late PSA recurrence in prostate cancer treated by prostatectomyM C Tsourlakis, E Walter, A Quaas, et al.
Prostate Cancer and Prostatic Diseases|January 16, 2013
Active surveillance: does serial prostate biopsy increase histological inflammation?A S Glass, S P Porten, M Bonham, et al.
Prostate Cancer and Prostatic Diseases|June 19, 2013
Selective estrogen receptor modulators for BPH: new factors on the groundM Garg, D Dalela, D Dalela, et al.
Prostate Cancer and Prostatic Diseases|February 6, 2013
Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancerG Schaefer, J-M Mosquera, R Ramoner, et al.
Prostate Cancer and Prostatic Diseases|September 11, 2013
High level of dioxin-TEQ in tissue is associated with Agent Orange exposure but not with biochemical recurrence after radical prostatectomyQ Li, L Lan, Z Klaassen, et al.
Prostate Cancer and Prostatic Diseases|August 7, 2013
Safety and efficacy of resistance exercise in prostate cancer patients with bone metastasesP Cormie, R U Newton, N Spry, et al.
Prostate Cancer and Prostatic Diseases|December 4, 2013
Anterior tumors of the prostate: clinicopathological features and outcomesJ Mygatt, I Sesterhenn, I Rosner, et al.
Prostate Cancer and Prostatic Diseases|October 30, 2013
[-2]proPSA is an early marker for prostate cancer aggressivenessI Heidegger, H Klocker, E Steiner, et al.
Pageof 199